HBI
61
13
HAS
44
2
CMG
47
-3
CFG
56
6
DD
41
3
DVA
72
2
FTI
71
7
KSS
13
-8
EL
30
2
CVS
64
2
DE
62
2
KMX
55
3
AZO
55
-8
VIX
52
-6
GS
62
14
CTAS
49
6
LB
64
2
BEN
36
2
COST
48
5
BDX
55
3
HBI
61
13
HAS
44
2
CMG
47
-3
CFG
56
6
DD
41
3
DVA
72
2
FTI
71
7
KSS
13
-8
EL
30
2
CVS
64
2
DE
62
2
KMX
55
3
AZO
55
-8
VIX
52
-6
GS
62
14
CTAS
49
6
LB
64
2
BEN
36
2
COST
48
5
BDX
55
3
Financhill
Back

Seres Therapeutics 10K Form

Sell
40

MCRB
Seres Therapeutics

Last Price:
$0.74
Seasonality Move:
-0.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MCRB News And Ratings

See the #1 stock for the next 7 days that we like better than MCRB

MCRB Financial Statistics

Sales & Book Value

Annual Sales: $126.3M
Cash Flow: $-39M
Price / Cash Flow: 0
Annual Sales: $0.08
Price / Book: 9.33

Profitability

EPS (TTM): -0.02000
Net Income (TTM): $136K
Gross Margin: $-3.5M
Return on Equity: 0%
Return on Assets: 0%

Seres Therapeutics Earnings Forecast

Key Seres Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for MCRB have been equal to 61.35% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 13 years have been positive in 7 years.

Seres Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MCRB
CUSIP: 81750R
Website: serestherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MCRB Technical Analysis vs Fundamental Analysis

Sell
40
Seres Therapeutics (MCRB) is a Sell

Is Seres Therapeutics a Buy or a Sell?